![](https://www.biorizon.es/wp-content/uploads/2023/02/sabana-post-150x150.webp)
Almeria’s microalgae with the ALGAENAUTS and SABANA projects, are in the European news thanks to EURONEWS
8 de February de 2023![](https://www.biorizon.es/wp-content/uploads/2023/04/stand-Fruit2022.png)
Fruit Attraction more active than ever
18 de April de 2023Biorizon Biotech presents its new products at Fruit Logistica 2023 after doubling sales last year
Biorizon Biotech, which presented its new line of products for regenerative agriculture at Fruit Logistica 2023 this year, has experienced a spectacular increase in sales last year. This new sales record was the result of rapid growth in EMEA and the Americas as well as the success of the new products launched in 2022.
Biorizon Biotech is a global player in the cultivation and commercialisation of microalgae-based biosolutions for agriculture. Our research and product development is not only based on microalgae but also in various microorganisms and plant extracts aimed at creating biostimulants and biopesticides to enhance Regenerative Agriculture.
The markets that have grown the most in the last year have been EMEA, where Biorizon Biotech has opened a subsidiary in Italy, joining the existing ones; LATAM with a particularly positive sales performance and ASIA which is emerging strongly.
New product lines are already in the pipeline
The launch of new product lines aimed at Regenerative Agriculture and new formulations using microalgae, bacteria and plant extracts under the proprietary Trietech technology, which are also responsible for this high growth, have been the focus of attention at Fruit Logistica 2023.
“Biorizon Biotech is fully committed to Regenerative Agriculture, biostimulants and new generation biopesticides. We believe that the global market will undergo a revolution with the development of these new products and we want to be part of it” said David Iglesias, CEO of Biorizon Biotech.
Biorizon Biotech will continue to grow in 2023
The growth forecast for 2023 will mark a new milestone for the Biorizon Group and new markets are being opened up in the continents where it is currently present, as well as in Asia and Oceania. Biorizon Biotech aims to operate in more than 40 markets this year.
The new facilities, the largest in Europe, in which selected strains of microalgae are cultivated and the expansion of bacterial production facilities will enable the expected growth to be met during 2023.
The market for biostimulants and biopesticides will see significant growth in the next 10 years, and strategies such as the EU’s “Farm to Fork” strategy and the new legislation approved in important countries such as the USA and Brazil strengthen this growth.
Biorizon Biotech is a member of the Global Climate Pact,and promotes numerous actions for sustainable cultivation and the reduction of the use of chemical products in agriculture.